119-hr4392

HR
✓ Complete Data

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Login to track bills
Introduced:
Jul 15, 2025
Policy Area:
Health

Bill Statistics

3
Actions
42
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Jul 15, 2025
Referred to the House Committee on Energy and Commerce.

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
Jul 15, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: Intro-H
Jul 15, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: 1000
Jul 15, 2025

Subjects (1)

Health (Policy Area)

Text Versions (1)

Introduced in House

Jul 15, 2025

Full Bill Text

Length: 5,244 characters Version: Introduced in House Version Date: Jul 15, 2025 Last Updated: Nov 14, 2025 6:13 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4392 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 4392

To authorize the Secretary of Health and Human Services to award grants
to increase early detection of and intervention for uterine fibroids,
and for other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

July 15, 2025

Ms. Brown (for herself, Ms. Clarke of New York, Ms. Sewell, Mrs.
Foushee, Ms. McClellan, Ms. Velazquez, Mr. Fields, Ms. Kelly of
Illinois, Mrs. Dingell, Ms. Tlaib, Mrs. Trahan, Mr. Johnson of Georgia,
Ms. Ansari, Mrs. Watson Coleman, Mr. David Scott of Georgia, Mr.
Thanedar, Mr. Thompson of Mississippi, Mr. Krishnamoorthi, Ms. Salinas,
Mrs. McIver, Mr. Carter of Louisiana, Ms. Meng, Ms. Wilson of Florida,
Ms. Lee of Pennsylvania, Ms. Simon, Ms. Wasserman Schultz, Mr. Figures,
Ms. Adams, Mr. Khanna, Ms. Underwood, Mr. Green of Texas, Ms. Tokuda,
Ms. Rivas, Mr. Mannion, Ms. Pressley, Ms. Titus, and Mr. Latimer)
introduced the following bill; which was referred to the Committee on
Energy and Commerce

_______________________________________________________________________

A BILL

To authorize the Secretary of Health and Human Services to award grants
to increase early detection of and intervention for uterine fibroids,
and for other purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

This Act may be cited as the ``Uterine Fibroid Intervention and
Gynecological Health Treatment Act of 2025''.
SEC. 2.

(a) In General.--The Secretary of Health and Human Services (in
this Act referred to as the ``Secretary'') shall--

(1) conduct or support research on increasing early
detection of, and intervention for, uterine fibroids; and

(2) based on the results of such research and other
relevant information, formulate evidence-based or evidence-
informed strategies to increase early detection in health care
settings.

(b) Timeline.--The Secretary shall finalize the evidence-based or
evidence-informed strategies required by subsection

(a)

(2) as
expeditiously as possible in order to make such strategies available to
grantees under
section 3 to implement such strategies pursuant to
section 3 (b) (3) .

(b)

(3) .
SEC. 3.
INTERVENTION.

(a) In General.--The Secretary of Health and Human Services (in
this Act referred to as the ``Secretary'') may award grants to States
for carrying out programs--

(1) to increase early detection of and intervention for
uterine fibroids; and

(2) to develop and implement public awareness and education
campaigns for the early detection and intervention of uterine
fibroids.

(b) Use of Funds.--A State receiving a grant under this section may
use the grant, with respect to increasing early detection of and
intervention for uterine fibroids, for the following activities:

(1) Screening procedures, including advanced gynecological
imaging (including payment therefor).

(2) Patient navigation services.

(3) Implementation of evidence-based or evidence-informed
strategies proven to increase early detection in health care
settings.

(4) Facilitating access to health care settings.
(c) Priority.--In awarding grants under this section, the Secretary
shall give priority to States proposing to carry out a program in a
geographic areas in which there are socially vulnerable populations
with elevated risk of uterine fibroid development.
SEC. 4.
INTERVENTION.

The Secretary may award grants to conduct research, which may
include clinical trials, related to--

(1) disparities in pain control and management in uterine
fibroid surgical treatment; or

(2) Asherman's Syndrome, intrauterine adhesions, and other
intrauterine conditions as determined appropriate by the
Secretary.
SEC. 5.

(a) Reports on Grants.--Not later 2 years after the initial award
of grants under this Act, and every 2 years thereafter, the Secretary
shall submit to the Congress, and make publicly available on the
appropriate website of the Department of Health and Human Services, a
report summarizing the findings and results of programs and activities
funded through grants under this Act.

(b) Report on Research Developments.--Not later than 2 years after
the date of enactment of this Act, and every 2 years thereafter, the
Secretary shall submit to the Congress, and make publicly available on
the appropriate website of the Department of Health and Human Services,
a report outlining research developments and findings related to--

(2) disparities in pain control and management in uterine
fibroid surgical treatment; and

(3) Asherman's Syndrome, intrauterine adhesions, and other
intrauterine conditions as determined appropriate by the
Secretary.
<all>